Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

May-12

AUTHORS : Prof Christopher G. Rowan (Details for study: Outcome, A Quintiles Company, Cambridge, MA, USA; crowan@outcome.com) now works at COHRDATA, INC, San Clemente, CA, US / Institute for Health, Health Care Policy, and Aging Research at Rutgers, 112 Paterson St New Brunswick, NJ 08901 – Email: crowan@cohrdata.com – Profile: https://pets.rutgers.edu/people/christopher-rowan/ AND http://www.cohrdata.com/about-us

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 21(5):494-506

DOI : 10.1002/pds.3199

Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study